CDK8 Antibody
-
中文名称:CDK8兔多克隆抗体
-
货号:CSB-PA162953
-
规格:¥1100
-
图片:
-
其他:
产品详情
-
Uniprot No.:P49336
-
基因名:CDK8
-
别名:cdk8 antibody; CDK8 protein kinase antibody; CDK8_HUMAN antibody; Cell Division Kinase 8 antibody; Cell division protein kinase 8 antibody; Cyclin Dependent kinase 8 antibody; Cyclin-dependent kinase 8 antibody; K35 antibody; Mediator complex subunit cdk8 antibody; Mediator of RNA polymerase II transcription subunit cdk8 antibody; Protein kinase K35 antibody
-
宿主:Rabbit
-
反应种属:Human,Mouse
-
免疫原:Synthetic peptide of Human CDK8
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
-
抗体亚型:IgG
-
纯化方式:Antigen affinity purification
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
产品提供形式:Liquid
-
应用范围:ELISA,IHC
-
推荐稀释比:
Application Recommended Dilution ELISA 1:2000-1:5000 IHC 1:25-1:100 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation.
-
基因功能参考文献:
- these observations suggest that Zyxin promotes colon cancer tumorigenesis in a mitotic-phosphorylation-dependent manner and through CDK8-mediated YAP activation. PMID: 29967145
- Genes coregulated by CDK8/19 and NFkappaB include IL8, CXCL1, and CXCL2. PMID: 28855340
- Moreover, it identified CDK19 and CDK8 to be specifically overexpressed during prostate cancer progression, highlighting their potential as novel therapeutic targets in advanced prostate cancer. PMID: 27678455
- identification of the Mediator-associated kinase CDK8, and its paralog CDK19, as negative regulators of IL-10 production during innate immune activation PMID: 28805801
- These results identify CDK8 as a novel downstream mediator of estrogen receptors (ER) and suggest the utility of CDK8 inhibitors for ER-positive breast cancer therapy PMID: 28147342
- Our data suggest for the first time that CDK8 appears to contribute to the malignant mechanism of LSCC and may represent a significant prognostic marker for LSCC patients. PMID: 28220308
- On stimulation of TLR9, CDK8/19 positively regulates inflammatory gene transcription in cooperation with NF-kappaB and C/EBPbeta. PMID: 28151579
- Data suggest that, during neurogenesis, Mediator complex cyclin-dependent kinases (CDK8, CDK19) interact directly with PRC2 (polycomb repressive complex 2) subunit EZH2 (enhancer of zeste homolog 2), as well as SUZ12 (suppressor of zeste 12 homolog). PMID: 26002960
- the expression of CDK8 and its interactive genes has a profound impact on the response to adjuvant therapy in breast cancer in accordance with the role of CDK8 in chemotherapy-induced tumor-supporting paracrine activities--{REVIEW} PMID: 26452386
- Data suggest that MED13, MED12, CDK8 and cyclin C (CycC) comprise a four-subunit "kinase" module of the Mediator complex that functions as a major ingress of oncogenic and developmental signaling/gene expression in humans. [REVIEW] PMID: 26182352
- our data provided evidence that CDK-8 played a significant role in colon cancer hepatic metastasis by regulating the Wnt/beta-catenin signal pathway PMID: 26349978
- Collectively, our results implicate Ste12 and Tec1 as general and important contributors to the Cdk8, RNAPII-CTD regulatory circuitry as it relates to the maintenance of genome integrity PMID: 26496706
- miR-101 is a potent tumor repressor that directly represses CDK8 expression PMID: 26286725
- Mediator-associated kinases CDK8 and CDK19 restrain increased activation of key super-enhancer-associated genes in acute myeloid leukaemia (AML) cells PMID: 26416749
- The Skp2-mH2A1-CDK8 axis has a critical role in breast cancer development via dysregulation of the G2/M transition, polyploidy, cell growth dysregulation, and loss of tumor suppression. PMID: 25818643
- Current state of the art confirms that further development of CDK8 inhibitors will translate into targeted therapies in oncology PMID: 26006748
- Microarrays identified target genes for each CDK, and we selected six genes: two target genes of CDK8, two target genes of CDK19 and two genes that were targets for both. PMID: 22117896
- Suggest that miR-107 plays a key role in cisplatin resistance by targeting the CDK8 protein in non small cell lung cancer cells. PMID: 25400821
- A novel transcriptional repression mechanism of hMED18 mediated by hCDK8 and further a novel positive role of free CDK/cyclin module in transcriptional activation is described. PMID: 24840924
- CDK8 regulates the transcription factors turnover, C-terminal domain phosphorylation, and regulates the activator or repressor functions. (Review) PMID: 24139904
- Cdk8 is required for stress-induced Mdv1-Dnm1 interaction and mitochondrial fragmentation. PMID: 24439911
- Here, loss of CDK8 suppressed the reduced mRNA expression and RNAPII occupancy levels of CTD truncation mutants. PMID: 24009531
- CDK8 and CDK19, individually interact with PRMT5 and WDR77, and their interactions with PRMT5 cause transcriptional repression of C/EBPbeta target genes. PMID: 23749998
- The phosphorylation of S375 by CDK8 regulates E2F1 ability to repress transcription of beta-catenin/TCF-dependent genes, as well as activation of E2F1-dependent genes. PMID: 22945643
- results show a reverse correlation between CDK8 levels and several key features of the endometrial cancer cells, including cell proliferation, migration and invasion as well as tumor formation in vivo PMID: 23454913
- Study reports that HIF1A employs a specific variant of the Mediator complex to stimulate RNAPII elongation; the Mediator-associated kinase CDK8, but not the paralog CDK19, is required for induction of many HIF1A target genes. PMID: 23746844
- s found that interaction of the CDK8 kinase module with Mediator's middle module interferes with C-terminal domain-dependent RNAPII binding to a previously unknown middle-module CTD-binding site and with the holoenzyme formation process. PMID: 23563140
- CDK8 is a key regulator of STAT1 and antiviral responses. PMID: 23352233
- 2.2-A crystal structure of CDK8/CycC in complex with sorafenib; the CDK8 activation loop appears not to be phosphorylated. Based on the structure, we discuss an alternate mode of CDK8 activation to the general CDK activation by T-loop phosphorylation PMID: 21806996
- Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities PMID: 22869755
- Retroviral cyclin enhances cyclin-dependent kinase-8 activity. PMID: 22379099
- we identify a role for the CDK8 oncogene in regulating tumor differentiation and stem cell pluripotency PMID: 22345154
- beta-catenin expression was suppressed by CDK8 interference in the gastric adenocarcinoma cell lines. PMID: 21344156
- significant inverse correlation between mH2A and CDK8 expression levels exists in melanoma patient samples PMID: 21179167
- CDK8 may identify a subset of colon cancer patients with poor prognosis. PMID: 20514474
- plays a role in mechanisms of transcriptional regulation upon protein phosphorylation. (review) PMID: 20408451
- Overexpression of CDK8 is associated with beta-catenin activation and colon cancer. PMID: 19790197
- The s show, using a human tumor cell line, that CDK8 is a positive regulator of genes within the serum response network, including several members of the activator protein 1 and early growth response family of oncogenic transcription factors. PMID: 20098423
- CDK8 play positive roles in transcriptional activation. PMID: 17212659
- RNA interference experiments demonstrate that CDK8 functions as a coactivator within the p53 transcriptional program. PMID: 17612495
- Within T/G-Mediator, cdk8 phosphorylates serine-10 on histone H3, which in turn stimulates H3K14 acetylation by GCN5L within the complex. PMID: 18418385
- by retaining RB1 and amplifying CDK8, colorectal tumour cells select conditions that collectively suppress E2F1 and enhance the activity of beta-catenin PMID: 18794899
- CDK8 kinase activity was necessary for beta-catenin-driven transformation and for expression of several beta-catenin transcriptional targets PMID: 18794900
- Med12--but not Med13--is essential for activating the CDK8 kinase. PMID: 19047373
- Med12 and Med13 are critical for human CDK8 subcomplex -dependent repression, whereas CDK8 kinase activity is not PMID: 19240132
显示更多
收起更多
-
亚细胞定位:Nucleus.
-
蛋白家族:Protein kinase superfamily, CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily
-
数据库链接:
HGNC: 1779
OMIM: 603184
KEGG: hsa:1024
STRING: 9606.ENSP00000370938
UniGene: Hs.382306
Most popular with customers
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
-
VDAC1 Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human, Mouse, Rat